Skip to content
Trial Master File Reference Model
Trial Master File Reference Model

(a Community Group now part of CDISC)

Current version: TMF Reference Model V3.3

  • Home
  • About the Model
    • About the Model
    • CDISC TMF Reference Model Steering Committee
    • Intellectual Property Rights Policy
  • Community Exchange
    • FAQs
    • Forums
    • Resources
    • Exchange Mechanism
      • EMS News
      • EMS Roundtables
    • Resources Archive
  • Change Requests
  • Help
  • Login
  • Subscribe
Trial Master File Reference Model
Trial Master File Reference Model

(a Community Group now part of CDISC)

  • Home
  • About the Model
    • About the Model
    • CDISC TMF Reference Model Steering Committee
    • Intellectual Property Rights Policy
  • Community Exchange
    • FAQs
    • Forums
    • Resources
    • Exchange Mechanism
      • EMS News
      • EMS Roundtables
    • Resources Archive
  • Change Requests
  • Help
  • Login
  • Subscribe

Reply To: Statement of Investigator for non-US Clinical Trial Sites

Home › Forums › Where do I file…. ? › Statement of Investigator for non-US Clinical Trial Sites › Reply To: Statement of Investigator for non-US Clinical Trial Sites

December 23, 2020 at 1:05 pm #3911
Eldin Rammell
Participant

Hi Maria
I would say it meets this definition: A regulatory statement from the investigator (required by certain health authorities).
Kind regards
Eldin

Post navigation
Next Reply →

Recent Discussion Topics

  • PIA (=privacy impact assessment)
    2 weeks ago
  • Declaration of Interest
    3 weeks, 2 days ago
  • Is eTMF access control necessary for multiple CROs?
    2 weeks, 2 days ago

Relevant Links

  • TMF Reference Model Initiative Charter
  • Webinar – EU CTR & eTMF Impact
  • CDISC Affiliation Position Paper
  • TMF Reference Model v3.2.1
  • EDM Reference Model
  • eTMF Exchange Mechanism Standard Presentation
  • eTMF Exchange Mechanism Standard v1.0.2

Copyright © 2023 Trial Master File Reference Model | Powered by Astra WordPress Theme